Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Dual Effects of Beta-Hydroxy-Beta-Methylbutyrate (HMB) on Amino Acid, Energy, and Protein Metabolism in the Liver and Muscles of Rats with Streptozotocin-Induced Type 1 Diabetes

M. Holeček, M. Vodeničarovová, R. Fingrová

. 2020 ; 10 (11) : . [pub] 20201023

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21026478

Grantová podpora
PROGRES Q40/02 Charles University

Beta-hydroxy-beta-methyl butyrate (HMB) is a unique product of leucine catabolism with positive effects on protein balance. We have examined the effects of HMB (200 mg/kg/day via osmotic pump for 7 days) on rats with diabetes induced by streptozotocin (STZ, 100 mg/kg intraperitoneally). STZ induced severe diabetes associated with muscle wasting, decreased ATP in the liver, and increased α-ketoglutarate in muscles. In plasma, liver, and muscles increased branched-chain amino acids (BCAAs; valine, isoleucine, and leucine) and decreased serine. The decreases in mass and protein content of muscles and increases in BCAA concentration were more pronounced in extensor digitorum longus (fast-twitch muscle) than in soleus muscle (slow-twitch muscle). HMB infusion to STZ-treated animals increased glycemia and serine in the liver, decreased BCAAs in plasma and muscles, and decreased ATP in the liver and muscles. The effects of HMB on the weight and protein content of tissues were nonsignificant. We concluded that fast-twitch muscles are more sensitive to STZ than slow-twitch muscles and that HMB administration to STZ-treated rats has dual effects. Adjustments of BCAA concentrations in plasma and muscles and serine in the liver can be considered beneficial, whereas the increased glycemia and decreased ATP concentrations in the liver and muscles are detrimental.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026478
003      
CZ-PrNML
005      
20211026132857.0
007      
ta
008      
211013s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/biom10111475 $2 doi
035    __
$a (PubMed)33114049
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Holeček, Milan $u Department of Physiology, Faculty of Medicine, Charles University, 500 38 Hradec Králové, Czech Republic
245    10
$a Dual Effects of Beta-Hydroxy-Beta-Methylbutyrate (HMB) on Amino Acid, Energy, and Protein Metabolism in the Liver and Muscles of Rats with Streptozotocin-Induced Type 1 Diabetes / $c M. Holeček, M. Vodeničarovová, R. Fingrová
520    9_
$a Beta-hydroxy-beta-methyl butyrate (HMB) is a unique product of leucine catabolism with positive effects on protein balance. We have examined the effects of HMB (200 mg/kg/day via osmotic pump for 7 days) on rats with diabetes induced by streptozotocin (STZ, 100 mg/kg intraperitoneally). STZ induced severe diabetes associated with muscle wasting, decreased ATP in the liver, and increased α-ketoglutarate in muscles. In plasma, liver, and muscles increased branched-chain amino acids (BCAAs; valine, isoleucine, and leucine) and decreased serine. The decreases in mass and protein content of muscles and increases in BCAA concentration were more pronounced in extensor digitorum longus (fast-twitch muscle) than in soleus muscle (slow-twitch muscle). HMB infusion to STZ-treated animals increased glycemia and serine in the liver, decreased BCAAs in plasma and muscles, and decreased ATP in the liver and muscles. The effects of HMB on the weight and protein content of tissues were nonsignificant. We concluded that fast-twitch muscles are more sensitive to STZ than slow-twitch muscles and that HMB administration to STZ-treated rats has dual effects. Adjustments of BCAA concentrations in plasma and muscles and serine in the liver can be considered beneficial, whereas the increased glycemia and decreased ATP concentrations in the liver and muscles are detrimental.
650    _2
$a aminokyseliny $x aplikace a dávkování $x farmakologie $7 D000596
650    _2
$a zvířata $7 D000818
650    _2
$a diabetes mellitus 1. typu $x chemicky indukované $x farmakoterapie $x metabolismus $7 D003922
650    _2
$a injekce intraperitoneální $7 D007274
650    _2
$a injekce subkutánní $7 D007279
650    _2
$a játra $x účinky léků $x metabolismus $7 D008099
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a kosterní svaly $x účinky léků $x metabolismus $7 D018482
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a streptozocin $x aplikace a dávkování $7 D013311
650    _2
$a valeráty $x aplikace a dávkování $x farmakologie $7 D014631
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vodeničarovová, Melita $u Department of Physiology, Faculty of Medicine, Charles University, 500 38 Hradec Králové, Czech Republic
700    1_
$a Fingrová, Radana $u Department of Physiology, Faculty of Medicine, Charles University, 500 38 Hradec Králové, Czech Republic
773    0_
$w MED00188737 $t Biomolecules $x 2218-273X $g Roč. 10, č. 11 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33114049 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026132903 $b ABA008
999    __
$a ok $b bmc $g 1715257 $s 1146985
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 10 $c 11 $e 20201023 $i 2218-273X $m Biomolecules $n Biomolecules $x MED00188737
GRA    __
$a PROGRES Q40/02 $p Charles University
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...